Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome

Apostolia M. Tsimberidou, William G. Wierda, Sijin Wen, William Plunkett, Susan O'Brien, Thomas J. Kipps, Jeffrey A. Jones, Xavier Badoux, Hagop Kantarjian, Michael J. Keating

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I-II clinical trial of oxaliplatin, fludarabine, cytarabine, and rituximab therapy in aggressive relapsed/refractory chronic lymphocytic leukemia or Richter syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences